Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index (COMETI P2)
This study is currently recruiting participants.
Verified April 2013 by Veridex, LLC
Sponsor:
Veridex, LLC
Collaborators:
University of Michigan Cancer Center
Dana-Farber Cancer Institute
Information provided by (Responsible Party):
Veridex, LLC
ClinicalTrials.gov Identifier:
NCT01701050
First received: October 1, 2012
Last updated: April 8, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | June 2015 |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |